直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Article

Navigating Evolving Standing Requirements for Appeals from the PTAB

October 23, 2019

Westlaw Journal Intellectual Property

By Michael J. Flibbert; Michelle G. Rice

After holding that an inter parte reexamination requester must establish Article III standing to appeal to the Federal Circuit (Consumer Watchdog), the court held that the “hard floor” standing requirements similarly apply to appeals from IPR proceedings (Phigenixi). Since then, the court has further defined the appellate standing requirements and dismissed a series of appeals from PTAB proceedings for lack of standing, such as JTEKT (2018), RPX (2018), Momenta (2019), AVX (2019), and most recently, GE.  Seeking Supreme Court review, IPR petitioners in JTEKT and RPX filed petitions for certiorari after the Federal Circuit dismissed their appeals.  They sought to directly challenge the Federal Circuit’s standing jurisprudence; however, the Supreme Court denied both petitions last month. As a result, Federal Circuit decisions remain controlling on standing.

In this article, Finnegan attorneys Mike Flibbert and Michelle Rice provide an overview of the current state of the law on appellate standing from the PTAB and offer practical guidance for appellants and appellees in strategically establishing or challenging standing to appeal. Comparing dismissed appeals with cases in which standing was found to exist (such as PPG (2017), DuPont (2018), Google (2018), and Amerigen (2019)), this article addresses the evidentiary requirements for establishing an “injury-in-fact,” taking into account the role of the appellant as a current or future competitor, licensee, or non-practicing entity.  Other key considerations include supplementing the PTAB or appellate record with standing evidence, such as affidavits or declarations specifying ongoing or future potentially infringing commercial activities, the patentee’s refusal to grant a covenant not to sue, any other relevant economic or commercial injuries, and any past or ongoing litigation between the parties. Timing issues can also be important: First, an appellant should consider strategically planning the timing of its PTAB petition and related commercial activities, so that by the time of any future appeal (typically about 18 months after a PTAB petition), sufficient standing evidence can be presented to the Federal Circuit. Second, an appellant should be cognizant that standing is required to exist both at the time of filing of a notice of appeal to the Federal Circuit as well as at all times during an appeal. Only by successfully navigating these and other standing requirements can an appellant have an opportunity to present its substantive arguments on the merits to the court.

Read the full article.

Tags

Article III Standing

Downloadable Files

  • PUBLISHED - Westlaw IP - Navigating Evolving Standing Requiremen

Related Practices

Federal Circuit and Supreme Court Appeals

Patent Office Invalidation Proceedings

Related Offices

Washington, DC

Related Professionals

Michael J. Flibbert
Partner
Washington, DC
+1 202 408 4493
Email
Michelle_Yongyuan_Rice
Michelle G. Rice
Associate
Washington, DC
+1 202 408 4229
Email

©2019 Thompson Reuters. Originally published by Westlaw Journal Intellectual Property. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm’s clients.

Related Insights

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Conference

International Trade Commission Litigation & Enforcement

May 4-5, 2026

Washington, DC

Articles

Choice of Law in Patent Appeals: The Federal Circuit’s Issue-by-Issue Framework

May/June 2026

Articles

Unpacking Squires’ Recent Discretionary Denial Guidance Focusing on American Manufacturing

April 24, 2026

Articles

Prosecution History Estoppel: Navigating Limits on Equivalents in Patent Litigation

March/April 2026

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics for December 2025 - February 2026

March 31, 2026

Conference

2026 PTAB Bar Association Annual Conference

March 18-20, 2026

Washington, DC

At the PTAB Blog

Made in the USA? USPTO Adds Manufacturing and Small-Business Factors to PTAB Discretion

March 13, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP